Comparing genomic landscape of early stage, treatment naïve and late stage, drug resistant EGFR-mutant lung adenocarcinomas

Comparing genomic landscape of early stage, treatment naïve and late stage, drug resistant EGFR-mutant lung adenocarcinomas

While, the genomic landscape of early stage, treatment naïve lung adenocarcinomas (LUADs) has been described quite elaborately in recent literature, the genomic profile of late stage, drug resistant tumors remains largely unknown. Further, most of the published studies are based on smoker dominated...

Full description

Bibliographic Details
Main Authors: Rahul Nahar, Yin Yeng Lee, Alexis J. Khng, Tong Zhang, Angela Takano, Xingliang Liu, Jacob J.S. Alvarez, Ori Zelichov, Ezra Ella, Zohar Barbash, Chong Hee Lim, Tina P.T. Koh, Zaw Win Aung, Tony Kiat Hon Lim, Chee Keong Toh, Wan-Teck Lim, Bing Lim, Wai Leong Tam, Eng-Huat Tan, Weiwei Zhai, Daniel S.W. Tan, Axel M. Hillmer
Format: Article
Language:English
Published: Science Planet Inc. 2017-12-01
Series:Canadian Journal of Biotechnology
Online Access:https://www.canadianjbiotech.com/CAN_J_BIOTECH/Archives/v1/Special Issue-Supplement/cjb.2017-a231.pdf

Internet

https://www.canadianjbiotech.com/CAN_J_BIOTECH/Archives/v1/Special Issue-Supplement/cjb.2017-a231.pdf

Similar Items